To switch or to swap? Evidence from a meta-analysis for the best treatment approach in childhood chronic uveitis resistant to the I anti-TNF

Objective: Since adalimumab approval in childhood chronic non-infectious uveitis (cNIU), the prognosis has been dramatically changed, but the 25 % failed to achieve inactivity. There is not accordance if it is better to switch to another anti-TNF or to swap to another category of biologic. Thus, we...

Full description

Saved in:
Bibliographic Details
Main Authors: Ilaria Maccora, Sara Soldovieri, Teodoro Oliverio, Salvatore de Masi, Edoardo Marrani, Ilaria Pagnini, Maria Vincenza Mastrolia, Gabriele Simonini
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Translational Autoimmunity
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589909024000170
Tags: Add Tag
No Tags, Be the first to tag this record!